Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Combodart Dosage
Combodart is indicated for the management of moderate to severe symptomatic benign prostatic
hyperplasia (BPH).
Combodart should be taken as:
- One capsule, once daily
- Taken at the same time each day
- 30 minutes after food
Important:
- Combodart should be swallowed whole, approximately 30 minutes after the same meal each day.
- Don’t chew or open the capsules, as contact with contents of the capsule may make the patient’s
mouth or throat sore - Ensure your patient does not stop taking Combodart or change dosage without first consulting you
Length of treatment:
- It is important that the patient continues to take Combodart for as long as you prescribe it, even if no immediate benefit is felt
- Some men notice an early improvement in symptoms, however others may need to continue for 3-6 months to see if Combodart helps them
- Patients must also continue to take Combodart as symptoms improve
Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Combodart is registered trademark of the GlaxoSmithKline Group of companies
